Results 191 to 200 of about 466,398 (341)

Supplemental Table S1 from PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory Pathways

, 2023
Brajesh P. Kaistha, Holger Lorenz, Harald Schmidt, Bence Sipos, Michael Pawlak, Berthold Gierke, Ramona Kreider, Brigitte Lankat–Buttgereit, Melanie Sauer, Lisa Fiedler, Anja Krattenmacher, Bettina Geisel, Johann M. Kraus, Kristopher K. Frese, Sabine Kelkenberg, Nathalia A. Giese, Hans A. Kestler, Thomas M. Gress, Malte Buchholz   +18 more
openalex   +2 more sources

Implications of gut microbiota in hepatic and pancreatic diseases: Gut-liver-pancreas axis. [PDF]

World J Hepatol
Abdelwahab MM, Ghattas AS, Tawheed A.
europepmc   +1 more source

PAR2: The Cornerstone of Pancreatic Diseases. [PDF]

Physiol Res, 2022
Suhaj P, Olejar T, Matej R.
europepmc   +1 more source

Nomogram to predict recurrent disease after curative pancreatic resection for patients with grade 1 or 2 non-functional neuroendocrine tumor: Identify the high risk patient [PDF]

, 2016
Anneke P. J. Jilesen, Casper H.J. van Eijck, Folkert J. van Kemenade, S. van Eeden, Joanne Verheij, Dirk J. Gouma, E.J.M. Nieveen van Dijkum   +6 more
openalex   +1 more source

CARD9 Conveys Pancreatic Islet Sympathetic Nervous β2 Signals to Reshape Macrophage Creatine Metabolism in Type 1 Diabetes

Advanced Science, EarlyView.
This study identifies CARD9 as a key mediator linking sympathetic β2‐adrenergic receptor signaling to macrophage creatine metabolism, inflammatory polarization, and neuronal integrity. Loss of β2‐AR‐PKA‐CREB1‐CARD9 signaling in macrophages reduces creatine uptake, promotes pro‐inflammatory macrophage activation, and drives sympathetic axon ferroptosis.
Huimin Yuan, Senlin Li, Shuai Liu, Hong Zhou, Yue Xu, Wenhui Li, Mengxuan Wang, Mengheng Wang, Mengzhu Zheng, Wenxi Shi, Xin Li, Yiting Feng, Ming Xiang   +12 more
wiley   +1 more source

Tube-bearing experience of patients with biliary and pancreatic diseases outside the hospital: based on qualitative study. [PDF]

BMC Gastroenterol
Liu J, Ye X, Chang S, Wu Z, Yuan B, Wang Q, Yao Y.   +6 more
europepmc   +1 more source

Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study. [PDF]

Front Immunol, 2023
Yuan S, Miao Y, Ruan X, Chen J, Li X, Larsson SC.   +5 more
europepmc   +1 more source

Expression and regulation of mTOR, a key modulator of ageing and age-related disease, in pancreatic carcinoma [PDF]

, 2019
Theodoros Kolokotronis, D. Avramis, Kathrin Kölsch, Claudia Rubie, Matthias Glanemann   +4 more
openalex   +1 more source

Supplementary Table S10 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization

, 2023
Sontoria D. King, Swathi Veliginti, Martijn C.G.J. Brouwers, Zhewen Ren, Wei Zheng, Veronica Wendy Setiawan, Lynne R. Wilkens, Xiao‐Ou Shu, Alan A. Arslan, Laura E. Beane Freeman, Paige M. Bracci, Federico Canzian, Mengmeng Du, Steven Gallinger, Graham G. Giles, Phyllis J. Goodman, Christopher A. Haiman, Manolis Kogevinas, Charles Kooperberg, Loı̈c Le Marchand, Rachel Ε. Neale, Kala Visvanathan, Emily White, Demetrius Albanes, Gabriella Andreotti, Ana Babić, Sonja I. Berndt, Lauren K. Brais, Paul Brennan, Julie E. Buring, Kari G. Rabe, William R. Bamlet, Stephen J. Chanock, Charles S. Fuchs, J. Michael Gaziano, Edward L. Giovannucci, Thilo Hackert, Manal M. Hassan, Verena Katzke, Robert C. Kurtz, I‐Min Lee, Núria Malats, Neil Murphy, Ann L. Oberg, Irene Orlow, Miquel Porta, Francisco X. Real, Nathaniel Rothman, Howard D. Sesso, Debra T. Silverman, Ian M. Thompson, Jean Wactawski‐Wende, Xiaoliang Wang, Nicolas Wentzensen, Herbert Yu, Anne Zeleniuch‐Jacquotte, Kai Yu, Brian M. Wolpin, Eric J. Duell, Donghui Li, Rayjean J. Hung, Sandra Pérdomo, Marjorie L. McCullough, Neal D. Freedman, Alpa V. Patel, Ulrike Peters, Elio Ríboli, Malin Sund, Anne Tjønneland, Jun Zhong, Stephen K. Van Den Eeden, Peter Kraft, Harvey A. Risch, Laufey T. Ámundadóttir, Alison P. Klein, Rachael Z. Stolzenberg‐Solomon, Samuel O. Antwi   +76 more
openalex   +1 more source

Genetic and Functional Evidence Links Germline Biallelic Inactivating Variants in WWOX to Histological Mixed‐Type Thyroid Cancer

Advanced Science, EarlyView.
The role of germline WWOX loss‐of‐function variants in oncogenesis has remained poorly characterized. This study provides the first comprehensive genetic and functional evidence that such variants promote tumorigenesis through the disruption of multiple tumor‐suppressive mechanisms.
Xiaopeng Zhang, Jian Qi, Jialiang Wang, Zhipeng Wang, Yongguang Wang, Zongtao Hu, Ao Xu, Bo Hong, Hongzhi Wang   +8 more
wiley   +1 more source